株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

院内感染 (HAI) :機器、医薬品、環境に配慮した製品

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

発行 BCC Research 商品コード 210214
出版日 ページ情報 英文 219 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.97円で換算しております。
Back to Top
院内感染 (HAI) :機器、医薬品、環境に配慮した製品 Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products
出版日: 2018年09月19日 ページ情報: 英文 219 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の院内感染 (HAI) 対策市場は、2018年の189億米ドルから、2023年までに247億米ドルまで拡大すると見られています。市場は、2018年〜2023年のCAGR (複合年間成長率) で、5.4%の成長が予測されています。

当レポートでは、世界の院内感染 (HAI) 対策市場について調査分析し、市場概要、市場動向分析と予測、地域別の市場分析、主要特許・研究開発、ベンダー情勢、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 概要

  • 院内感染 (HAI)
  • 感染症の種類
  • 医療の場における疾患と感染症
  • 発生率と有病率
  • 危険因子
  • 予防戦略

第4章 市場サマリーと分析

  • 世界の感染対策市場
  • 市場促進要因
  • 市場抑制要因
  • アンメットニーズ

第5章 医薬品

  • HAI医薬品市場
  • 抗生物質
  • 抗真菌薬
  • 抗ウイルス薬とワクチン

第6章 環境治療

  • HAI:環境治療市場
  • 消毒
  • 患者皮膚用製品
  • 環境滅菌

第7章 医療機器

  • HAI:医療機器市場
  • 抗菌コーティング
  • 患者用換気装置
  • IVフィルター

第8章 産業構造

  • 医療感染予防の産業構造

第9章 研究と機会

  • 新しい技術
  • 抗生物質パイプライン
  • ウイルス感染パイプライン:B型肝炎とC型肝炎
  • ウイルス感染インフルエンザのパイプライン
  • 真菌感染パイプライン

第10章 特許分析

  • 医薬品
  • 環境滅菌
  • 医療機器

第11章 企業プロファイル

  • 製薬企業
    • GILEAD SCIENCES
    • MERCK
    • NOVARTIS
    • PFIZER
    • ROCHE
    • SANOFI, SANOFI PASTEUR
    • SEQIRUS
  • 滅菌/消毒産業の企業
    • 3M HEALTHCARE
    • ADVANCED STERILIZATION PRODUCTS
    • BECTON, DICKINSON AND COMPANY
    • BELIMED
    • STERIGENICS
    • THE CLOROX COMPANY
    • XENEX DISINFECTION SERVICES
    • Medical Device Companies
    • BACTIGUARD
    • TELEFLEX

第12章 付録

図表

List of Tables

  • Summary Table A: Global Market for HCAI Control, by Segment, Through 2023
  • Summary Table B: Global Market for HCAI Control, by Region, Through 2023
    • Table 1: Pooled Cumulative Incidence Density, HCAI and Device-Associated Infections in Adults, 1995-2010
    • Table 2: HCAIs, LTACHs and IRFs in the U.S., 2014
    • Table 3: SSI Rates for Select Procedures, U.S., 2014
    • Table 4: Sterilization and Disinfection Methods, CDC Guidelines, Updated February 2017
    • Table 5: Air-Handling Systems in Healthcare, CDC Recommendations, Updated February 2017
    • Table 6: Controlling Spread of Waterborne Infections, CDC Recommendations, Updated February 2017
    • Table 7: Routine Prevention of Waterborne Microbial Contamination Within the Distribution System, CDC Recommendations, Updated February 2017
    • Table 8: Proportion of Resistant Strains, by WHO Region
    • Table 9: WHO Priority List, Pathogens for R&D of New Antibiotics
    • Table 10: Administrative Measures, MDROs, CDC Recommendations, Updated 2006
    • Table 11: Education and Training, MDROs, CDC Recommendations, Updated 2006
    • Table 12: Judicious Use of Antimicrobial Agents, MDROs, CDC Recommendations, Updated 2006
    • Table 13: Surveillance, MDROs, CDC Recommendations, Updated 2006
    • Table 14: Appropriate Urinary Catheter Use, CDC Recommendations, Updated 2009
    • Table 15: Urinary Catheter Maintenance, CDC Recommendations, Updated 2009
    • Table 16: Summary of Recommendations, CRBSI, CDC, Updated 2011
    • Table 17: SSI, CDC Recommendations, Updated 2017
    • Table 18: Dialysis, CDC Recommendations, Updated 2016
    • Table 19: Core Components of IPC Programs at the National and Acute Healthcare Facility Level, HCAI, WHO Recommendations, Updated 2016
    • Table 20: Surveillance Elements and Methodology, CDC, Updated 2006
    • Table 21: Global Market for HCAI Control, by Segment, Through 2023
    • Table 22: Global Market for HCAI Control, by Region, Through 2023
    • Table 23: Global Market for HCAI Pharmaceuticals, by Category, Through 2023
    • Table 24: Proportion of Resistant Strains, by WHO Region
    • Table 25: WHO Priority List, Pathogens for R&D of New Antibiotics
    • Table 26: Select Branded Antibiotics, by Manufacturer
    • Table 27: Global Market for HCAI Antibiotics, by Class (ATC Code), Through 2023
    • Table 28: Global Market for HCAI Antibiotics, by Region, Through 2023
    • Table 29: Select Branded Antifungals, by Manufacturer
    • Table 30: Global Market for HCAI Antifungals, by Class, Through 2023
    • Table 31: Global Market for HCAI Antifungals, by Region, Through 2023
    • Table 32: Key Marketed Hepatitis B Drugs
    • Table 33: Global Market for Hepatitis B Therapeutics for HCAI, by Region, Through 2023
    • Table 34: Global Market for Hepatitis B Vaccines for HCAI, by Region, Through 2023
    • Table 35: Key Marketed Hepatitis C Drugs
    • Table 36: Global Market for Hepatitis C Therapeutics for HCAI, by Region, Through 2023
    • Table 37: Key Marketed Influenza Vaccines
    • Table 38: Key Marketed Antivirals for Influenza
    • Table 39: Global Market for Influenza Vaccines for HCAI, by Region, Through 2023
    • Table 40: Global Market for HCAI Environment Treatment, by Category, Through 2023
    • Table 41: Select Branded Disinfectants, by Manufacturer
    • Table 42: Global Market for Disinfectant Use in Hospitals, by Region, Through 2023
    • Table 43: Select Branded Skin Antiseptics (Preoperative Care), by Manufacturer
    • Table 44: Global Market for Presurgical Skin Preparation, by Region, Through 2023
    • Table 45: Global Market for Air-Filtration for Hospital Use, by Region, Through 2023
    • Table 46: Global Market for High-Temperature Sterilization, by Region, Through 2023
    • Table 47: Global Market for Low-Temperature Sterilization, by Category, Through 2023
    • Table 48: Global Market for Low-Temperature Sterilization, by Region, Through 2023
    • Table 49: Global Market for Radiation-based Sterilization, by Category, Through 2023
    • Table 50: Global Market for Radiation-based Sterilization, by Region, Through 2023
    • Table 51: Global Market for HCAI Medical Devices, by Category, Through 2023
    • Table 52: Global Market for Coated Catheter, by Category, Through 2023
    • Table 53: Global Market for Coated Catheter, by Region, Through 2023
    • Table 54: Global Market for Coated Endotracheal Tube, by Region, Through 2023
    • Table 55: Global Market for IV Filter, by Region, Through 2023
    • Table 56: Global Antibiotics Development Pipeline
    • Table 57: Hepatitis B and Hepatitis C Clinical Pipeline
    • Table 58: Influenza A and Influenza B Clinical Pipeline
    • Table 59: Antifungal Clinical Pipeline
    • Table 60: Number of Published Patent Applications for Antibiotics, 2014-2017
    • Table 61: Number of Published Patent Applications for Hepatitis B, 2014-2017
    • Table 62: Number of Published Patent Applications for Hepatitis C, 2014-2017
    • Table 63: Number of Published Patent Applications for Influenza, 2014-2017
    • Table 64: Number of Published Patent Applications for Antifungals, 2014-2017
    • Table 65: Number of Published Patent Applications for Disinfectants, 2014-2017
    • Table 66: Number of Published Patent Applications for Patient Skin Preparation, 2014-2017
    • Table 67: Number of Published Patent Applications for Air Treatment, 2014-2017
    • Table 68: Number of Published Patent Applications for Water Treatment, 2014-2017
    • Table 69: Number of Published Patent Applications for Catheters and ETTs, 2014-2017
    • Table 70: Abbreviations Used in Global Markets for Infectious Diseases
    • Table 71: Glossary of Terms Used in Global Markets for Infectious Diseases
    • Table 72: Report Sources

List of Figures

  • Summary Figure A: Global Market for HCAI Control, by Segment, 2017-2023
  • Summary Figure B: Global Market for HCAI Control, by Region, 2017-2023
    • Figure 1: Antibiotic Use* by Class, Select Classes, 2000 and 2010
    • Figure 2: Global Market for HCAI Control, by Segment, 2017-2023
    • Figure 3: Global Market for HCAI Control, by Region, 2017-2023
    • Figure 4: Global Market for HCAI Pharmaceuticals, by Category, 2017-2023
    • Figure 5: Antibiotic Use* by Class, Select Classes, 2000 and 2010
    • Figure 6: Global Market for HCAI Antibiotics, by Class (ATC Code), 2017-2023
    • Figure 7: Global Market for HCAI Antibiotics, by Region, 2017-2023
    • Figure 8: Global Market for HCAI Antifungals, by Class, 2017-2023
    • Figure 9: Global Market for HCAI Antifungals, by Region, 2017-2023
    • Figure 10: Global Market for Hepatitis B Therapeutics for HCAI, by Region, 2017-2023
    • Figure 11: Global Market for Hepatitis B Vaccines for HCAI, by Region, 2017-2023
    • Figure 12: Global Market for Hepatitis C Therapeutics for HCAI, by Region, 2017-2023
    • Figure 13: Global Market for Influenza Vaccines for HCAI, by Region, 2017-2023
    • Figure 14: Global Market for HCAI Environment Treatment, by Category, 2017-2023
    • Figure 15: Global Market for Disinfectant Use in Hospitals, by Region, 2017-2023
    • Figure 16: Global Market for Presurgical Skin Preparation, by Region, 2017-2023
    • Figure 17: Global Market for Air-Filtration for Hospital Use, by Region, 2017-2023
    • Figure 18: Global Market for High-Temperature Sterilization, by Region, 2017-2023
    • Figure 19: Global Market for Low-Temperature Sterilization, by Category, 2017-2023
    • Figure 20: Global Market for Low-Temperature Sterilization, by Region, 2017-2023
    • Figure 21: Global Market for Radiation-based Sterilization, by Category, 2017-2023
    • Figure 22: Global Market for Radiation-based Sterilization, by Region, 2017-2023
    • Figure 23: Global Market for HCAI Medical Devices, by Category, 2017-2023
    • Figure 24: Global Market for Coated Catheter, by Category, 2017-2023
    • Figure 25: Global Market for Coated Catheter, by Region, 2017-2023
    • Figure 26: Global Market for Coated Endotracheal Tube, by Region, 2017-2028
    • Figure 27: Global Market for IV Filter, by Region, 2017-2023
    • Figure 28: HCAI-Prevention Industry Structure
目次
Product Code: HLC092D

Report Highlights:

The global market for healthcare-acquired infection (HCAI) control should grow from $18.9 billion in 2018 to $24.7 billion by 2023 at a compound annual growth rate (CAGR) of 5.4% from 2018 through 2023.

The global market for environment sterilization in HCAI control should grow from $9.0 billion in 2018 to $12.4 billion by 2023 at a CAGR of 6.8% from 2018 through 2023.

The global market for pharmaceuticals in HCAI control should grow from $5.6 billion in 2018 to nearly $7.0 billion by 2023 at a CAGR of 4.3% from 2018 through 2023.

Report Scope:

The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g. catheters, patient ventilation devices, sterile IV filters) that prevent occurrence of nosocomial infections.

Within each type of treatment, regional analyses will focus on the Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries).

Report Includes:

  • 42 data tables and 32 additional tables
  • Industry analysis of the global healthcare-acquired infection (HCAI) control market
  • Detailed overview and trend analysis of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent these infections
  • Analyses of global market trends with data from 2017, estimates for 2018 and projections of compound annual growth rates (CAGRs) through 2023
  • Emphasis on selected devices, pharmaceuticals and environmental products currently employed or under development for treatment of viral, bacterial and fungal infections
  • Analysis of antimicrobial resistance and more specifically antibiotic resistance as a cause for these infections
  • A look at the hospital surveillance methods and tools currently being used to prevent these infections
  • Regional analysis of the market covering Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa); and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries)
  • Information on key patents and newer research developments in sterilization systems and devices
  • Examination of vendor landscape and profiles of key players in the HCAI market, including Novartis, Pfizer, Roche, 3M Healthcare and Sanofi Pasteur

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Overview

  • Healthcare-Acquired Infections
  • Types of Infections
    • Central-Line-Associated Bloodstream Infections
    • Surgical Site Infections
    • Catheter-Associated Urinary Tract Infections
    • Ventilator-Associated Pneumonia
  • Diseases and Infectious Agents in Healthcare Settings
    • Acinetobacter
    • Burkholderia cepacia
    • Clostridium difficile
    • Clostridium sordellii
    • Enterobacteriaceae (Carbapenem-Resistant)
    • Gram-Negative Bacteria
    • Hepatitis
    • HIV/AIDS
    • Influenza
    • Klebsiella
    • Methicillin-Resistant Staphylococcus aureus
    • Mycobacterium abscessus
    • Norovirus
    • Pseudomonas aeruginosa
    • Staphylococcus aureus
    • Vancomycin-Resistant Enterococci
  • Incidence and Prevalence
  • Risk Factors
  • Prevention Strategies
    • Basic Infection Prevention and Control
    • Antibiotics and Multidrug-Resistant Organisms
    • Device-Associated Infection Control
    • Procedure-Associated Guidelines
    • Setting Specific Guidelines
    • WHO Guidelines
    • Surveillance Systems

Chapter 4: Market Summary and Analysis

  • Global Infection control Market
    • Region-wise Analysis
  • Market Drivers
    • Antimicrobial Resistance
    • Increasing Population and Demographic Changes
    • Emerging Markets
    • New Technologies
    • Vaccine Coverage
    • Increase in Focus on HCAIs
  • Market Deterrents
    • Cost-Effectiveness of Newer Methods
  • Unmet Needs
    • Effective Treatment for "Superbugs"

Chapter 5: Pharmaceuticals

  • HCAI Pharmaceuticals Market
  • Antibiotics
    • Mechanism of Action
    • Antibiotics Resistance
    • Mechanisms of Antibiotic Resistance
    • Reasons for Antibiotic Resistance
    • Antimicrobial Resistance (Antibiotics) -- Incidence
    • Antibiotic Resistance -- Hospitals, Healthcare Settings
    • Davos Declaration for Combating Antimicrobial Resistance
    • Antibiotics for Bacterial HCAI
    • Select Marketed Antibiotics
    • Global Antibiotics Market
  • Antifungal Drugs
    • Antifungals for HCAI
    • Select Marketed Antifungals
    • Global Antifungals Market
  • Antivirals and Vaccines
    • Hepatitis B and Hepatitis C
    • Influenza

Chapter 6: Environmental Treatment

  • HCAI: Environmental Treatment Market
  • Disinfectants
    • Key Marketed Hospital-Use Disinfectants
  • Patient Skin Preparation
    • Key Marketed Patient Skin Preparation Antiseptics
    • Patient Skin Preparation Market
  • Environment Sterilization
    • Air Treatment
    • Room Filtration Systems
    • Room Pressurization
    • UV Light Disinfection
    • Water Treatment
    • Equipment/Facility Sterilization
    • Heat Sterilization
    • Chemical Sterilization
    • Radiation-based Sterilization
    • Environment Sterilization Market

Chapter 7: Medical Devices

  • HCAI: Medical Devices Market
  • Antimicrobial Coatings
    • Catheters
  • Patient Ventilation Devices
    • Types of Ventilation Devices
  • IV Filters
    • IV Filter Market

Chapter 8: Industry Structure

  • Industry Structure for Healthcare Infection Prevention
    • Suppliers
    • Customers
    • Consumers

Chapter 9: Research and Opportunities

  • New Technologies
    • Hand Hygiene
    • Patient Tracing
    • Self-Disinfecting Surfaces
    • Automated Decontamination Technologies
    • Smart Systems and Predictive Analytics
    • Other Technologies
  • Antibiotics Pipeline
  • Viral Infection Pipeline -- Hepatitis B and Hepatitis C
  • Pipeline of Viral Infection Influenza
  • Fungal Infection Pipeline

Chapter 10: Patent Analysis

  • Pharmaceuticals
    • Antibiotics
    • Hepatitis B
    • Hepatitis C
    • Influenza
    • Antifungals
  • Environment Sterilization
    • Disinfectants
    • Patient Skin Preparation
    • Air Treatment
    • Water Treatment
  • Medical Devices
    • Catheters and Endotracheal Tubes
    • IV Filters (In-Line)

Chapter 11: Company Profiles

  • Pharmaceutical Companies
    • GILEAD SCIENCES
    • MERCK
    • NOVARTIS
    • PFIZER
    • ROCHE
    • SANOFI, SANOFI PASTEUR
    • SEQIRUS
  • Companies in Sterilization/Disinfection Industry
    • 3M HEALTHCARE
    • ADVANCED STERILIZATION PRODUCTS
    • BECTON, DICKINSON AND COMPANY
    • BELIMED
    • STERIGENICS
    • THE CLOROX COMPANY
    • XENEX DISINFECTION SERVICES
    • Medical Device Companies
    • BACTIGUARD
    • TELEFLEX

Chapter 12: Appendix

Back to Top